Alzheimer's drug TB006 safety trial halted early
Disease control
Terminated
This study looked at the long-term safety of a drug called TB006 in people with Alzheimer's disease. It included people who had already been in a previous TB006 study and new participants. The study was stopped early, and its main goal was to track side effects and how the drug m…
Phase: PHASE2 • Sponsor: TrueBinding, Inc. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC